Safety and Efficacy Study of Pertuzumab to Treat Castration-Resistant Prostate Cancer
NCT00058539 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 42
Last updated 2015-06-23
Summary
The purpose of this study is to evaluate safety and efficacy of Omnitarg (Pertuzumab) on cancerous lesions in men with castration-resistant (hormone-refractory) prostate cancer.
Conditions
Interventions
- DRUG
-
rhuMAb 2C4 (pertuzumab)
Sponsors & Collaborators
-
Genentech, Inc.
lead INDUSTRY
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- MALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2003-04-30
- Primary Completion
- 2004-10-31
- Completion
- 2004-10-31
More Related Trials
-
Bortezomib in Patients With Metastatic Castration-Resistant Prostate Cancer With PTEN Deletion
NCT06029998 ·Status: RECRUITING ·Phase: PHASE2
-
Trastuzumab in Treating Patients With Prostate Cancer
NCT00003740 ·Status: COMPLETED ·Phase: PHASE2
-
Substudy 01A: Safety and Efficacy of Opevesostat (MK-5684)-Based Treatment Combinations or Opevesostat Alone in Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-5684-01A)
NCT06353386 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Pertuzumab, Trastuzumab, Hyaluronidase-zzxf and Enzalutamide for Treatment of Metastatic Castration-Resistant Prostate Cancer
NCT05730712 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Investigate the Effects of Orteronel on the QT/QTc Interval in Patients With Metastatic Castration-Resistant Prostate Cancer
NCT01549951 ·Status: COMPLETED ·Phase: PHASE2
-
Mitoxantrone Following Surgery in Treating Patients With Prostate Cancer at High Risk for Recurrence
NCT00003858 ·Status: WITHDRAWN ·Phase: PHASE2
-
A Study of Abiraterone Acetate (JNJ-212082) and Prednisolone in Patients With Advanced Prostate Cancer
NCT01685983 ·Status: COMPLETED ·Phase: PHASE2
-
Enzalutamide and Mifepristone in Treating Patients With Metastatic Hormone Resistant Prostate Cancer
NCT02012296 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Study of Enzalutamide in Patients With Castration-resistant Prostate Cancer
NCT01942837 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Olaparib (Lynparza™) Versus Enzalutamide or Abiraterone Acetate in Men With Metastatic Castration-Resistant Prostate Cancer (PROfound Study)
NCT02987543 ·Status: COMPLETED ·Phase: PHASE3
-
Vaccine Treatment for Hormone Refractory Prostate Cancer
NCT00105053 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Olaparib for the Treatment of Castration Resistant Prostate Adenocarcinoma
NCT04951492 ·Status: TERMINATED ·Phase: PHASE2
-
Androgen Deprivation Therapy and Vorinostat Followed by Radical Prostatectomy in Treating Patients With Localized Prostate Cancer
NCT00589472 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Investigate Efficacy and Safety of Different Dose Regimen of Oral Cabazitaxel Tablet in Adult Participants with Prostate Cancer
NCT06890832 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
NCT06136650 ·Status: RECRUITING ·Phase: PHASE3
-
An Open-label Study of the Effect of Tomivosertib (eFT508) in Patients With Advanced Castrate-resistant Prostate Cancer
NCT03690141 ·Status: TERMINATED ·Phase: PHASE2
-
Vorinostat and 177Lu-PSMA-617 for the Treatment of PSMA-Low Metastatic Castration-Resistant Prostate Cancer
NCT06145633 ·Status: RECRUITING ·Phase: PHASE2
-
Surgery in Treating Patients With Prostate Cancer
NCT00002938 ·Status: COMPLETED ·Phase: PHASE2
-
Genistein in Treating Patients With Prostate Cancer
NCT01126879 ·Status: TERMINATED ·Phase: PHASE2
-
Management of Castration-Resistant Prostate Cancer with Oligometastases
NCT02685397 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2/PHASE3
-
Cilengitide in Treating Patients With Prostate Cancer
NCT00121238 ·Status: COMPLETED ·Phase: PHASE2
-
ESK981 in Treating Patients With Metastatic Castrate-Resistant Prostate Cancer
NCT03456804 ·Status: COMPLETED ·Phase: PHASE2
-
Phase 2 Study of G-202 in Patients With Chemotherapy-Naïve Metastatic Castrate-Resistant Prostate Cancer
NCT01734681 ·Status: WITHDRAWN ·Phase: PHASE2
-
Study of OGX-011 Given Prior to Radical Prostatectomy in Patients With Localized Prostate Cancer
NCT00138918 ·Status: COMPLETED ·Phase: PHASE2
-
Combination of Entinostat and Enzalutamide in Advanced Prostate Cancer
NCT03829930 ·Status: TERMINATED ·Phase: PHASE1